Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AEMETIS, INCAMTX · Entity 6595 | Director | January 19, 2017 | January 21, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AEMETIS, INC
Report date January 19, 2017 · Filed January 21, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.72 · Expires 2027-01-19 | Direct | 40,000 |
Reported balance
After 2017-01-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-01-19 · Grant · Acquired 40,000 · Balance 40,000 F1: 100% vest Immediately |
Filing footnotes · ownership attribution and instrument terms
F1: 100% vest Immediately
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 19, 2017 Filed Jan 21, 2017 00:58 UTC | AEMETIS, INC AMTX · Entity 6595 | GrantOption (right to buy) · Derivative | 40,000 | $0.00 Strike: $1.72 | $0.00 |
DisclosureSEC source: 0001593968-17-000128 · primary_01.xml · derivative · entry 1 Sorgenti Harold · CIK 0001420115 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common stock and Series B Preferred · 40,000 shares Expires 2027-01-19 F1 · derivative.exercise_date: 100% vest Immediately Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.